Logo image of MSPR

MSP RECOVERY INC (MSPR) Stock Fundamental Analysis

NASDAQ:MSPR - Nasdaq - US5537453087 - Common Stock - Currency: USD

1.92  -0.04 (-2.04%)

After market: 1.87 -0.05 (-2.6%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MSPR. MSPR was compared to 102 industry peers in the Health Care Providers & Services industry. MSPR has a bad profitability rating. Also its financial health evaluation is rather negative. MSPR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MSPR had negative earnings in the past year.
MSPR had a negative operating cash flow in the past year.
In the past 5 years MSPR always reported negative net income.
In the past 5 years MSPR reported 4 times negative operating cash flow.
MSPR Yearly Net Income VS EBIT VS OCF VS FCFMSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -100M -200M -300M -400M -500M

1.2 Ratios

MSPR's Return On Assets of -3.49% is on the low side compared to the rest of the industry. MSPR is outperformed by 63.73% of its industry peers.
The Return On Equity of MSPR (-32.40%) is worse than 70.59% of its industry peers.
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROIC N/A
ROA(3y)-11.27%
ROA(5y)-34.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSPR Yearly ROA, ROE, ROICMSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 50 -50 -100

1.3 Margins

The Gross Margin of MSPR (66.22%) is better than 87.25% of its industry peers.
MSPR's Gross Margin has declined in the last couple of years.
MSPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
MSPR Yearly Profit, Operating, Gross MarginsMSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

MSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
MSPR has less shares outstanding than it did 1 year ago.
The debt/assets ratio for MSPR is higher compared to a year ago.
MSPR Yearly Shares OutstandingMSPR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1B 2B 3B
MSPR Yearly Total Debt VS Total AssetsMSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of -1.22, we must say that MSPR is in the distress zone and has some risk of bankruptcy.
MSPR's Altman-Z score of -1.22 is on the low side compared to the rest of the industry. MSPR is outperformed by 83.33% of its industry peers.
A Debt/Equity ratio of 2.54 is on the high side and indicates that MSPR has dependencies on debt financing.
MSPR has a worse Debt to Equity ratio (2.54) than 78.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Altman-Z -1.22
ROIC/WACCN/A
WACC4.09%
MSPR Yearly LT Debt VS Equity VS FCFMSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.01 indicates that MSPR may have some problems paying its short term obligations.
MSPR's Current ratio of 0.01 is on the low side compared to the rest of the industry. MSPR is outperformed by 96.08% of its industry peers.
MSPR has a Quick Ratio of 0.01. This is a bad value and indicates that MSPR is not financially healthy enough and could expect problems in meeting its short term obligations.
MSPR's Quick ratio of 0.01 is on the low side compared to the rest of the industry. MSPR is outperformed by 96.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
MSPR Yearly Current Assets VS Current LiabilitesMSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for MSPR have decreased strongly by -1533.49% in the last year.
The Revenue has grown by 24.67% in the past year. This is a very strong growth!
MSPR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -17.83% yearly.
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.78%
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%

3.2 Future

The Earnings Per Share is expected to grow by 181.53% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 163.31% on average over the next years. This is a very strong growth
EPS Next Y264.17%
EPS Next 2Y198.76%
EPS Next 3Y181.53%
EPS Next 5YN/A
Revenue Next Year203.87%
Revenue Next 2Y200.77%
Revenue Next 3Y163.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MSPR Yearly Revenue VS EstimatesMSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 10B 20B 30B 40B
MSPR Yearly EPS VS EstimatesMSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 200 400 600 800 1K

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

MSPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
MSPR is valuated cheaply with a Price/Forward Earnings ratio of 0.03.
MSPR's Price/Forward Earnings ratio is rather cheap when compared to the industry. MSPR is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.86. MSPR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.03
MSPR Price Earnings VS Forward Price EarningsMSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MSPR Per share dataMSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200

4.3 Compensation for Growth

MSPR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MSPR's earnings are expected to grow with 181.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y198.76%
EPS Next 3Y181.53%

More info and screens

0

5. Dividend

5.1 Amount

MSPR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MSP RECOVERY INC

NASDAQ:MSPR (5/2/2025, 8:11:21 PM)

After market: 1.87 -0.05 (-2.6%)

1.92

-0.04 (-2.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)05-14 2025-05-14
Inst Owners18.54%
Inst Owner Change0%
Ins Owners9.61%
Ins Owner Change0%
Market Cap15.82M
Analysts82.86
Price TargetN/A
Short Float %20.34%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.03
P/S 1.47
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-101.6
EYN/A
EPS(NY)76.47
Fwd EY3983.07%
FCF(TTM)-3.51
FCFYN/A
OCF(TTM)-3.2
OCFYN/A
SpS1.3
BVpS36.45
TBVpS-299.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.22%
FCFM N/A
ROA(3y)-11.27%
ROA(5y)-34.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.53%
Cap/Sales 23.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -1.22
F-Score3
WACC4.09%
ROIC/WACCN/A
Cap/Depr(3y)42.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.78%
EPS Next Y264.17%
EPS Next 2Y198.76%
EPS Next 3Y181.53%
EPS Next 5YN/A
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%
Revenue Next Year203.87%
Revenue Next 2Y200.77%
Revenue Next 3Y163.31%
Revenue Next 5YN/A
EBIT growth 1Y12.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.17%
OCF growth 3YN/A
OCF growth 5YN/A